← SynDRA

CRENOLANIB

SynDRA canonical compound SYN0031590 — structure-anchored drug synonym record

All known targets

• PDGFRA
• PDGFRB
• FLT3
• CSF1R
• KIT
• SRC

Mechanisms of action (all sources)

• PDGFR inhibitor
• PDGFRB INHIBITOR
• Platelet-derived growth factor receptor inhibitor
• PDGFRA INHIBITOR
• FLT3 INHIBITOR
• Tyrosine-protein kinase receptor FLT3 inhibitor
• CSF1R INHIBITOR
• KIT INHIBITOR
• PDGFR tyrosine kinase receptor inhibitor
• PDGFRA MODULATOR
• SRC INHIBITOR

Drug classes

• Antineoplastic Agents

Cross-references

• PubChem CID: 10366136
• ChEMBL: CHEMBL2105728
• DrugBank: DB11832
• ChEBI: 145365
• KEGG: D10102
• PDB: 6T2
• Wikipedia: Crenolanib
• TTD: D0J1GR
• LINCS BRD: BRD-K22127577

Synonyms

• ARO-002
• CP-868596
• CP-868,596
• Crenolanib (CP-868596)
• UNII-LQF7I567TQ
• LQF7I567TQ
• CP-868596 (Crenolanib)
• [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine
• 1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
• CP868569
• 1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine
• J-502712
• 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
• CP 868596
• ARO 002
• Crenolanib [USAN]
• Crenolanib (USAN)
• MFCD21609260
• 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine
• 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.
• 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1H-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine
• CP-868
• CP868596
• Crenolanib [USAN:INN]
• crenolanibum
• 6T2
• CP-868569
• CRENOLANIB [INN]
• Crenolanib,CP-868596
• CRENOLANIB [WHO-DD]
• MLS006010956
• Crenolanib - CP-868569
• GTPL7882
• SCHEMBL2730601
• CHEMBL2105728
• DTXSID50985873
• EX-A215
• CHEBI:145365